Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. VAZKEPA (Icosapent ethyl)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

VAZKEPA (Icosapent ethyl)

Medicine - Posted on Feb 08 2022
Active substance (DCI)
  • Icosapent ethyl
history (1)
  • 12/15/21

    VAZKEPA (isocapent éthyl)

    Première évaluation. Avis favorable au remboursement uniquement chez les patients adultes sous traitement par statine à dose...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • C10AX06
Manufacturer
AMARIN
Presentation

VAZKEPA 998 mg, capsule molle
1 flacon de 120 capsules - (Code CIP : 34009 302 361 9 2)

All our publications
    Drug therapy Embolism, thrombosis and stenosis Heart failure Hypertension Metabolic diseases Myocardial ischemia

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
BjWGgyVst0Eb4NN2